Objectives: We hypothesized that prehopsital ECG scores can identify ST-segment elevation myocardial infarction (STEMI) patients in whom time delay is particularly important for myocardial salvage. Methods: We evaluated the Anderson-Wilkins (AW) score (which designates the acuteness of ischemia) and grade 3 ischemia (GI3) (which identifies severe ischemia) in the prehospital ECG and compared them to the myocardial salvage index (MSI) assessed by cardiac magnetic resonance. Results: In 150 patients, system delay (alarm to balloon inflation) (β = -0.304, p < 0.001) and AW score (β = 0.364, p < 0.001) correlated with MSI. AW scores ≥3 (p < 0.001) and GI3 (p = 0.002) predicted the MSI. We formed 4 subgroups combining AW scores (<3 or ≥3) and grades of ischemia (<GI3 or =GI3), yielding a prehospital salvage score of 1-4, which predicted the MSI (p < 0.001), left ventricular ejection fraction at 3 months (p = 0.017), infarct size (p < 0.001), and troponin T (p < 0.001). MSI was only dependent on system delay in patients with acute ischemia (AW score = 3) with (β = -0.687, p = 0.005) or without (β = -0.454, p < 0.001) severe ischemia (GI3). Conclusion: In patients with STEMI, the novel prehospital salvage score identifies subgroups in which myocardial salvage is particularly time dependent.

1.
Francone M, Bucciarelli-Ducci C, Carbone I, et al: Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:2145-2153.
2.
Brodie BR, Webb J, Cox DA, et al: Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). Am J Cardiol 2007;99:1680-1686.
3.
Tarantini G, Cacciavillani L, Corbetti F, et al: Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005;46:1229-1235.
4.
Eitel I, Desch S, Fuernau G, et al: Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55:2470-2479.
5.
Schömig A, Ndrepepa G, Mehilli J, et al: Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 2003;108:1084-1088.
6.
Aquaro GD, Pingitore A, Strata E, et al: Relation of pain-to-balloon time and myocardial infarct size in patients transferred for primary percutaneous coronary intervention. Am J Cardiol 2007;100:28-34.
7.
Lønborg J, Schoos MM, Kelbæk H, et al: Impact of system delay on infarct size, myocardial salvage index and left ventricular function in patients with ST-segment elevation myocardial infarction. Am Heart J 2012;164:538-546.
8.
Terkelsen CJ, Sørensen JT, Maeng M, et al: System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010;304:763-771.
9.
Abete P, Ferrara N, Cacciatore F, et al: Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 1997;30:947-954.
10.
Ishihara M, Sato H, Tateishi H, et al: Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997;30:970-975.
11.
Lønborg J, Kelbæk H, Vejlstrup N, et al: Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 2012;13:433-443.
12.
Birnbaum Y, Herz I, Sclarovsky S, et al: Prognostic significance of the admission electrocardiogram in acute myocardial infarction. J Am Coll Cardiol 1996;27:1128-1132.
13.
Billgren T, Maynard C, Christian TF, et al: Grade 3 ischemia on the admission electrocardiogram predicts rapid progression of necrosis over time and less myocardial salvage by primary angioplasty. J Electrocardiol 2005;38:187-194.
14.
Weaver JC, Rees D, Prasan AM, et al: Grade 3 ischemia on the admission electrocardiogram is associated with severe microvascular injury on cardiac magnetic resonance imaging after ST elevation myocardial infarction. J Electrocardiol 2011;44:49-57.
15.
Birnbaum Y, Kloner RA, Sclarovsky S, et al: Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 trial). Am J Cardiol 1996;78:396-403.
16.
Sejersten M, Birnbaum Y, Ripa RS, et al: Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial. Heart 2006;92:1577-1582.
17.
Wilkins ML, Pryor AD, Maynard C, et al: An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. Am J Cardiol 1995;75:617-620.
18.
Corey KE, Maynard C, Pahlm O, et al: Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion acheivable size limitation. Am J Cardiol 1999;83:826-831.
19.
Engblom H, Strauss DG, Heden B, et al: The evaluation of an electrocardiographic myocardial ischemia acuteness score to predict the amount of myocardial salvage achieved by early percutaneous coronary intervention: clinical validation with myocardial perfusion single photon emission computed tomography and cardiac magnetic resonance. J Electrocardiol 2009;44:525-532.
20.
Sejersten M, Ripa RS, Maynard C, et al: Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a Danish Trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy. Am Heart J 2007;154:61.
21.
Lønborg J, Vejlstrup N, Kelbæk H, et al: Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 2012;33:1491-1499.
22.
Surawicz B, Childers R, Deal BJ, et al: AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. 3. Intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009;53:976-981.
23.
Birnbaum Y, Sclarovsky S: The grades of ischemia on the presenting electrocardiogram of patients with ST elevation acute myocardial infarction. J Electrocardiol 2001;34:17-26.
24.
Postma S, Heestermans T, ten Berg JW, et al: Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Electrocardiol 2011;44:516-522.
25.
Carlsson M, Ubachs JF, Hedström E, et al: Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging 2009;2:569-576.
26.
Lønborg J, Vejlstrup N, Mathiasen A, et al: Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols. J Cardiovasc Magn Reson 2011;13:50.
27.
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-2555.
28.
Oldgren J, Wernroth L, Stenestrand U, et al: Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA. Heart 2010;96:1451-1457.
29.
Denktas AE, Anderson HV, McCarthy J, et al: Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv 2011;4:599-604.
30.
Boersma E, Maas AC, Deckers JW, et al: Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-775.
31.
Reimer KA, Lowe JE, Rasmussen MM, et al: The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
32.
Alegria JR, Miller TD, Gibbons RJ, et al: Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J 2007;154:743-750.
33.
Solomon SD, Anavekar NS, Greaves S, et al: Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. J Am Coll Cardiol 2004;43:1511-1514.
34.
Mather A, Crean A, Abidin N, et al: Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:61.
35.
Marso SP, Miller T, Rutherford BD, et al: Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD trial). Am J Cardiol 2007;100:206-210.
36.
Desch S, Eitel I, Schmitt J, et al: Effect of coronary collaterals on microvascular obstruction as assessed by magnetic resonance imaging in patients with acute ST-elevation myocardial infarction treated by primary coronary intervention. Am J Cardiol 2009;104:1204-1209.
37.
Pinto DS, Kirtane AJ, Nallamothu BK, et al: Hospital delays in reperfusion for ST-elevation myocardial infarction. Circulation 2006;114:2019-2025.
38.
Pinto DS, Frederick PD, Chakrabarti AK, et al: Benefit of transferring ST-segment elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011;124:2512-2521.
39.
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg P, James SK, et al: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
40.
Ripa RS, Persson E, Hedén B, et al: Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction. J Electrocardiol 2005;38:96-99.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.